Answers are grounded in this paper and cite their sources.
In high-income countries, viral load is routinely used for monitoring HIV patients on antiretroviral therapy for early detection of drug failure. This is not the case in most resource limited settings like ours where only WHO immunological and clinical criteria are used for monitoring. This study is aimed at determining the rate/time of failure to 1 st and 2 nd antiretroviral drugs in children in our centers.
No takes yet. Share an insight, caveat, or question.
AA Okechukwu (2015) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: